T. Yamamoto et al., EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA ISOFORMS IN HUMAN GLOMERULAR-DISEASES, Kidney international, 49(2), 1996, pp. 461-469
Protein and mRNA expression of TGF-beta isoforms, TGF-beta 1, -beta 2
and -beta 3, and deposition of fibronectin containing extra domain A (
fibronectin EDA+) and plasminogen activator inhibitor-1 (PAI-1) were s
tudied in human chronic glomerulonephritis and diabetic nephropathy. N
ormal kidneys showed similar, weak immunostaining for all three TGF-be
ta isoforms. TGF-beta mRNA expression was weak for all isoforms with T
GF-beta 1 > TGF-beta 3 much greater than TGF-beta 2. In thin basement
membrane disease and minimal change disease, disorders where extracell
ular matrix accumulation is not a feature, immunoreactivity and mRNA e
xpression did not differ from normal. In contrast, diseases characteri
zed by extracellular matrix accumulation (IgA nephropathy, focal and s
egmental glomerulosclerosis, crescentic glomerulonephritis, lupus neph
ritis and diabetic nephropathy) all showed significantly increased exp
ression of the three TGF-beta isoforms in glomeruli and the tubulointe
rstitium. While glomerular and tubulointerstitial deposition of two ma
trix components induced by TGF-beta, fibronectin EDA+ and PAI-1, was s
ignificantly elevated in all diseases with matrix accumulation, correl
ation analysis revealed a close relationship primarily with TGF-beta 1
. We conclude that, for a spectrum of human glomerular disorders, incr
eased protein expression of all three TGF-beta isoforms and proteins i
nduced by TGF-beta is associated with pathological accumulation of ext
racellular matrix.